RhumbLine Advisers’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.21M	Sell	231,733 -37,644	-14%	-$524K	﹤0.01%	1618
2025 Q4	$3.78M	Sell	269,377 -8,557	-3%	-$120K	﹤0.01%	1541
2025 Q3	$3.89M	Sell	277,934 -89,865	-24%	-$1.29M	﹤0.01%	1562
2025 Q2	$5.53M	Buy	367,799 +24,510	+7%	+$350K	﹤0.01%	1353
2025 Q1	$4.53M	Sell	343,289 -86,773	-20%	-$1.2M	﹤0.01%	1409
2024 Q4	$6.79M	Buy	430,062 +44,722	+12%	+$672K	0.01%	1257
2024 Q3	$6.12M	Buy	385,340 +7,125	+2%	+$115K	0.01%	1319
2024 Q2	$5.76M	Sell	378,215 -93,910	-20%	-$1.35M	0.01%	1311
2024 Q1	$6.93M	Sell	472,125 -6,410	-1%	-$93.6K	0.01%	1244
2023 Q4	$6.66M	Buy	478,535 +31,620	+7%	+$423K	0.01%	1258
2023 Q3	$5.98M	Buy	446,915 +2,185	+0.5%	+$29.6K	0.01%	1248
2023 Q2	$5.61M	Buy	+444,730	New	+$5.19M	0.01%	1307
2013 Q3	–	Sell	-301,500	Closed	-$2.28M	–	2987
2013 Q2	$2.28M	Buy	+301,500	New	+$2.2M	0.01%	1217